Singapore: Less Than Three Months Left For Companies To Prepare For New Pharma Rules
Executive Summary
Singapore's efforts to consolidate and streamline the regulatory control of all health products under a single legislation has resulted in the fine-tuning of certain regulatory provisions that drug companies should be aware of.